![Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)](https://static.cymitquimica.com/products/3D/img/FT180391.png "Clique para ampliar")
Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)
CAS: 179162-34-6
Ref. 3D-FT180391
| 5mg | 136,00 € | ||
| 10mg | 167,00 € | ||
| 25mg | 300,00 € | ||
| 50mg | 440,00 € | ||
| 100mg | 626,00 € |
Informação sobre produto
- Tetrakis(1-((4-Alkyl(C11-C13)Phenylsulfo N-Yl)-(2S)-Pyrrolidinecarboxylate)Dirhod
- Tetrakis[(S)-(-)-N-(p-dodecylphenylsulfonyl)prolinato]dirhodium(II) Rh2(S-DOSP)4
Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-2S-pyrrolidinecarboxylate]dirhodium(II) is an organoiridium compound that can be used to synthesize vinyldiazoacetates. This compound is immobilized on a support and reacts with ethyl diazoacetate in the presence of prolinate to afford the corresponding vinyldiazoacetate. Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-2S-pyrrolidinecarboxylate]dirhodium(II) has been shown to be able to inhibit monoamine reuptake and exhibit antiinflammatory properties, which may be due to its ability to block the uptake of norepinephrine and serotonin.
Propriedades químicas
Consulta técnica sobre: 3D-FT180391 Tetrakis[1-[[4-alkyl(C11-C13)phenyl]sulfonyl]-(2S)-pyrrolidinecarboxylate]dirhodium(II)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
